The correlation between metabolic syndrome and prostatic diseases

European Urology

Volumn 61, Issue 3, 2012, Pages 560-570

  De Nunzio, Cosimo ^a   Aronson, William ^b   Freedland, Stephen J ^c   Giovannucci, Edward ^d   Parsons, J Kellogg ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Benign prostatic hyperplasia; Insulin resistance; Metabolic syndrome; Obesity; Prostate; Prostate cancer

Indexed keywords

BASIC RESEARCH; CANCER GROWTH; CARCINOGENESIS; CLINICAL RESEARCH; DISEASE ASSOCIATION; DYSLIPIDEMIA; EPIDEMIC; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MEDICAL LITERATURE; METABOLIC SYNDROME X; OBESITY; PEER REVIEW; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; REVIEW;

HUMANS; MALE; META-ANALYSIS AS TOPIC; METABOLIC SYNDROME X; PREVALENCE; PROSTATIC DISEASES;

EID: 84856381421     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.11.013     Document Type: Review

References (73)

1. M.G. Kirby, A. Wagg, and L. Cardozo Overactive bladder: is there a link to the metabolic syndrome in men? Neurourol Urodyn 29 2010 1360 1364
2. E. Kassi, P. Pervanidou, G. Kaltsas, and G. Chrousos Metabolic syndrome: definitions and controversies BMC Med 9 2011 48 60
3. I. Gorbachinsky, H. Akpinar, and D.G. Assimos Metabolic syndrome and urologic diseases Rev Urol 12 2010 157 180
4. J.K. Parsons, H.B. Carter, and A.W. Partin Metabolic factors associated with benign prostatic hyperplasia J Clin Endocrinol Metab 91 2006 2562 2568 (Pubitemid 44024618)
5. A. Alcaraz, P. Hammerer, A. Tubaro, F.H. Schröder, and R. Castro Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review Eur Urol 55 2009 864 875
6. C. De Nunzio, G. Kramer, and M. Marberger The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation Eur Urol 60 2011 106 117
7. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
8. A. Briganti, U. Capitanio, and N. Suardi Benign prostatic hyperplasia and its aetiologies Eur Urol Suppl 8 2009 865 871
9. D.E. Irwin, I. Milsom, and S. Hunskaar Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol 50 2006 1306 1315 (Pubitemid 44692945)
10. A.M. De Marzo, E.A. Platz, and S. Sutcliffe Inflammation in prostate carcinogenesis Nat Rev Cancer 7 2007 256 259
11. S. Moul, and K.T. McVary Lower urinary tract symptoms, obesity and the metabolic syndrome Curr Opin Urol 20 2010 7 12
12. A.W. Hsing, L.C. Sakoda, and S. Chua Jr. Obesity, metabolic syndrome, and prostate cancer Am J Clin Nutr 86 2007 843 857
13. W.C. Buschemeyer III, and S.J. Freedland Obesity and prostate cancer: epidemiology and clinical implications Eur Urol 52 2007 331 343 (Pubitemid 46963472)
14. A. Gupta, and V. Gupta Metabolic syndrome: what are the risks for humans? Biosci Trends 4 2010 204 212
15. R.J. Barnard Prostate cancer prevention by nutritional means to alleviate metabolic syndrome Am J Clin Nutr 86 2007 889 893
16. G.M. Reaven Banting lecture 1988. Role of insulin resistance in human disease Diabetes 37 1988 1595 1607 (Pubitemid 19004941)
17. S.M. Grundy, H.B. Brewer Jr. , J.I. Cleeman, S.C. Smith Jr., and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438 (Pubitemid 38133916)
18. S.M. Grundy, J.I. Cleeman, and S.R. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752 (Pubitemid 41532612)
19. P.L. Huang A comprehensive definition for metabolic syndrome Dis Model Mech 2 2009 231 237
20. G.M. Reaven The metabolic syndrome: time to get off the merry-go-round? J Intern Med 269 2011 127 136
21. L. Duvnjak, and M. Duvnjak The metabolic syndrome - an ongoing story J Physiol Pharmacol 60 Suppl 7 2009 19 24
22. R.B. Ervin Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006 Natl Health Stat Report 13 2009 1 7
23. T.H. Ngo, R.J. Barnard, P.S. Leung, P. Cohen, and W.J. Aronson Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival Endocrinology 144 2003 2319 2324 (Pubitemid 36629883)
24. G. Penna, N. Mondaini, and S. Amuchastegui Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia Eur Urol 51 2007 524 533 (Pubitemid 44937795)
25. S. Devaraj, U. Singh, and I. Jialal Human C-reactive protein and the metabolic syndrome Curr Opin Lipidol 20 2009 182 189
26. S. Rohrmann, A.M. De Marzo, E. Smit, E. Giovannucci, and E.A. Platz Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III) Prostate 62 2005 27 33 (Pubitemid 39614290)
27. S. Rohrmann, E. Smith, E. Giovannucci, and E.A. Platz Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III) Int J Obes (Lond) 29 2005 310 316 (Pubitemid 40333230)
28. A.V. Sarma, J.K. Parsons, K. McVary, and J.T. Wei Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms - what do we know? J Urol 182 2009 32 37
29. S. Rohrmann, W.G. Nelson, and N. Rifai Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III) Urology 69 2007 708 713 (Pubitemid 46574931)
30. D.S. Coffey Similarities of prostate and breast cancer: evolution, diet, and estrogens Urology 57 2001 31 38
31. J.K. Parsons Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems J Urol 178 2007 395 401 (Pubitemid 47030484)
32. J. Hammarsten, B. Hogstedt, N. Holthuis, and D. Mellstrom Components of the metabolic syndrome - risk factors for the development of benign prostatic hyperplasia Prostate Cancer Prostatic Dis 1 1998 157 162 (Pubitemid 128545860)
33. C. Ozden, O.L. Ozdal, G. Urgancioglu, H. Koyuncu, S. Gokkaya, and A. Memis The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia Eur Urol 51 2007 199 206 (Pubitemid 44821513)
34. V. Kupelian, K.T. McVary, and S.A. Kaplan Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey J Urol 182 2009 616 624
35. A. Firas, A. Briganti, and N. Suardi Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention Korean J Urol 52 2011 507 516
36. R.P. Kopp, M. Ham, A.W. Partin, E. Humphies, S.J. Freedland, and J.K. Parsons Obesity and prostate enlargement in men with localized prostate cancer BJU Int 108 2011 1750 1755
37. F. Cruz, and F. Desgrandchamps New concepts and pathophysiology of lower urinary tract symptoms in men Eur Urol Suppl 9 2010 472 476
38. J. Hammarsten, and B. Hogstedt Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 2001 151 158 (Pubitemid 32171181)
39. C. Temml, R. Obermayr, M. Marszalek, M. Rauchenwald, S. Madersbacher, and A. Ponholzer Are lower urinary tract symptoms influenced by metabolic syndrome? Urology 73 2009 544 548
40. G.S. Hong, B.S. Shim, W.S. Chung, and H. Yoon Correlation between metabolic syndrome and lower urinary tract symptoms of males and females in the aspect of gender specific medicine: a single institutional study Korean J Urology 51 2010 631 635
41. A. Gupta, S. Gupta, M. Pavuk, and C.G. Roehrborn Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of air force veterans Urology 68 2006 1198 1205 (Pubitemid 44880381)
42. H.K. Park, H.W. Lee, and K.S. Lee Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population Urology 72 2008 556 560
43. Gao Y, Wang M, Zhang H, et al. Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey. Urology. In press. doi:10.1016/j.urology.2011.07.1399.
44. K. Ohgaki, N. Hikima, K. Horiuchi, and Y. Kondo Association between metabolic syndrome and male lower urinary tract symptoms in Japanese subjects using three sets of criteria for metabolic syndrome and international prostatic symptom score Urology 77 2011 1432 1438
45. S.J. Freedland Obesity and prostate cancer: a growing problem Clin Cancer Res 11 2005 6763 6766 (Pubitemid 41428728)
46. J.R. Jaggers, X. Sui, and S.P. Hooker Metabolic syndrome and risk of cancer mortality in men Eur J Cancer 45 2009 1831 1838
47. E. Giovannucci, E.B. Rimm, M.J. Stampfer, G.A. Colditz, and W.C. Willett Diabetes mellitus and risk of prostate cancer Cancer Causes Control 9 1988 3 9
48. H. Li, M.J. Stampfer, and L. Mucci A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival Clin Chem 56 2010 34 43
49. J.A. Laukkanen, D.E. Laaksonen, L. Niskanen, E. Pukkala, A. Hakkarainen, and J.T. Salonen Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study Cancer Epidemiol Biomarkers Prev 13 2004 1646 1650 (Pubitemid 39331887)
50. H.L. Lund, T.F. Wisloff, I. Holme, and P. Nafstad Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years Am J Epidemiol 164 2006 769 774 (Pubitemid 44522081)
51. R.M. Martin, L. Vatten, D. Gunnell, P. Romundstad, and T.I. Nilsen Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway Cancer Causes Control 20 2009 1181 1192
52. J.L. Beebe-Dimmer, N.L. Nock, and C. Neslund-Dudas Racial differences in risk of prostate cancer associated with metabolic syndrome Urology 74 2009 185 190
53. A.J. Tande, E.A. Platz, and A.R. Folsom The metabolic syndrome is associated with reduced risk of prostate cancer Am J Epidemiol 164 2006 1094 1102 (Pubitemid 44851745)
54. C. De Nunzio, S.J. Freedland, and R. Miano A. Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy Prostate 71 2011 1492 1498
55. S.J. Freedland, E. Giovannucci, and E.A. Platz Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 17 2006 5 9 (Pubitemid 43083664)
56. L.P. Wallner, H. Morgenstern, and M.E. McGree The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study BJU Int 107 2011 929 935
57. R.J. Hamilton, and S.J. Freedland Review of recent evidence in support of a role for statins in the prevention of prostate cancer Curr Opin Urol 18 2008 333 339 (Pubitemid 351489386)
58. A.M. Mondul, S. Clipp, K.J. Helzlsouer, and E.A. Platz Association between plasma cholesterol concentration and incident prostate cancer in the CLUE cohort Cancer Causes Control 21 2010 61 68
59. J.B. Meigs, B. Mohr, M.J. Barry, M.M. Collins, and J.B. McKinlay Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men J Clin Epidemiol 54 2001 935 944 (Pubitemid 32771319)
60. S. Rohrmann, C.J. Crespo, J.R. Weber, E. Smit, E. Giovannucci, and E.A. Platz Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey BJU Int 96 2005 77 82 (Pubitemid 40942873)
61. J.K. Parsons, and C. Kashefi Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms Eur Urol 53 2008 1228 1235
62. S.J. Freedland, J. Mavropoulos, and A. Wang Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis Prostate 68 2008 11 19
63. S.J. Freedland, and W.J. Aronson Dietary intervention strategies to modulate prostate cancer risk and prognosis Curr Opin Urol 19 2009 263 267
64. N. Kobayashi, R.J. Barnard, and J. Said Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model Cancer Res 68 2008 3066 3073 (Pubitemid 351556309)
65. P. Mukherjee, A.V. Sotnikov, H.J. Mangian, J.R. Zhou, W.J. Visek, and S.K. Clinton Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression J Natl Cancer Inst 91 1999 512 523 (Pubitemid 29157059)
66. T.H. Ngo, R.J. Barnard, and P. Cohen Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in SCID mice and the IGF axis Clin Cancer Res 9 2003 2734 2743 (Pubitemid 36842120)
67. D. Ornish, L.W. Scherwitz, and J.H. Billings Intensive lifestyle changes for reversal of coronary heart disease JAMA 280 1998 2001 2007 (Pubitemid 28562678)
68. W.J. Aronson, R.J. Barnard, and S.J. Freedland Growth inhibitory effect of a low-fat diet on prostate cancer cells: results of a prospective randomized dietary intervention trial in men with prostate cancer J Urol 183 2009 345 350
69. T.H. Ngo, R.J. Barnard, C.N. Tymchuk, P. Cohen, and W.J. Aronson Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro Cancer Causes Control 13 2002 929 935 (Pubitemid 36169476)
70. Y. Liu, F. Hu, and D. Li Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis Eur Urol 60 2011 1029 1044
71. I.W. Mills, A. Crossland, A. Patel, and H. Ramonas Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement Eur Urol 52 2007 503 509 (Pubitemid 46963443)
72. M. Jalving, J.A. Gietema, and J.D. Lefrandt Metformin: taking away the candy for cancer? Eur J Cancer 46 2010 2369 2380
73. C.J. Keto, E.M. Masko, and S.J. Freedland Physical activity, obesity, and lower urinary tract symptoms Eur Urol 60 2011 1181 1183